Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer.

Abstract

Trastuzumab (TTZ) is molecular targeted drug used for metastatic breast cancer patients overexpressing human epidermal growth factor receptor 2 (HER2). Therapeutic effects of lymphocytes activated with TTZ (TTZ-LAK) using xenograft mouse models of human breast cancer (MDA-MB-453) cells were examined in vivo. Remarkable reduction of tumor volume in a… (More)

Topics

Cite this paper

@article{Nakagawa2013TherapeuticEO, title={Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer.}, author={Shinichiro Nakagawa and Yusuke Matsuoka and Hideaki Ichihara and Hitoji Yoshida and Kenshi Yoshida and Ryuichi Ueoka}, journal={Biological & pharmaceutical bulletin}, year={2013}, volume={36 5}, pages={861-5} }